In last trading session, Foghorn Therapeutics Inc (NASDAQ:FHTX) saw 0.87 million shares changing hands with its beta currently measuring 3.06. Company’s recent per share price level of $4.84 trading at -$0.02 or -0.41% at ring of the bell on the day assigns it a market valuation of $269.79M. That closing price of FHTX’s stock is at a discount of -111.78% from its 52-week high price of $10.25 and is indicating a premium of 39.26% from its 52-week low price of $2.94. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.19 million shares which gives us an average trading volume of 123.41K if we extend that period to 3-months.
For Foghorn Therapeutics Inc (FHTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Foghorn Therapeutics Inc (NASDAQ:FHTX) trade information
Upright in the red during last session for losing -0.41%, in the last five days FHTX remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $4.84 price level, adding 5.1% to its value on the day. Foghorn Therapeutics Inc’s shares saw a change of -7.63% in year-to-date performance and have moved 2.54% in past 5-day. Foghorn Therapeutics Inc (NASDAQ:FHTX) showed a performance of 12.56% in past 30-days. Number of shares sold short was 1.47 million shares which calculate 13.11 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 16.5 to the stock, which implies a rise of 70.67% to its current value. Analysts have been projecting 9 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -85.95% in reaching the projected high whereas dropping to the targeted low would mean a loss of -85.95% for stock’s current value.
Foghorn Therapeutics Inc (FHTX) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.59% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 20.09% while estimates for its earnings growth in next 5 years are of 6.99%.
Foghorn Therapeutics Inc (NASDAQ:FHTX)’s Major holders
Insiders are in possession of 18.95% of company’s total shares while institution are holding 72.70 percent of that, with stock having share float percentage of 89.69%. Investors also watch the number of corporate investors in a company very closely, which is 72.70% institutions for Foghorn Therapeutics Inc that are currently holding shares of the company. FLAGSHIP PIONEERING INC. is the top institutional holder at FHTX for having 12.67 million shares of worth $72.88 million. And as of 2024-06-30, it was holding 24.5716 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 6.38 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.3754 of outstanding shares, having a total worth of $36.7 million.
